McCracken Brendan Michael 4

What Happened

Brendan McCracken, President & CEO and a director of Ovintiv Inc. (OVV), was granted 1,109 restricted share units (RSUs) on March 31, 2026. The transaction is reported as an award/other acquisition (code A) of derivative securities; the reported acquisition price is $0 and the filing lists a total value of $0 because these RSUs are dividend-equivalent units rather than a cash payment.

Key Details

• Transaction date: 2026-03-31; Filing date (Form 4): 2026-04-02 (appears timely).
• Transaction type/code: Award/Acquisition (A), derivative security (RSUs); reported price: $0.
• Shares/units granted: 1,109 RSUs (dividend-equivalent RSUs).
• Shares owned after transaction: Not disclosed in this filing.
• Footnotes:
  • Each RSU represents the economic equivalent of one Ovintiv common share and yields dividend-equivalent RSUs; vesting/exercise follow the Omnibus Incentive Plan and the applicable grant agreement.
  • These RSUs were issued in lieu of cash dividends for Q1 2026.

Context

This was an equity award (dividend-equivalent RSUs), a routine compensation/adjustment event rather than an open-market purchase or sale. Dividend-equivalent RSUs increase the insider’s future share exposure if and when they vest/exercise, but they do not represent an outright cash purchase or sale and should be interpreted differently from buys or sells when assessing insider sentiment.